ClinicalTrials.Veeva

Menu

Hyperbaric Oxygen and Fibromyalgia: Randomised Prospective Clinical Trial

S

Shamir Medical Center (Assaf-Harofeh)

Status

Completed

Conditions

Fibromyalgia

Treatments

Other: Hyperbaric oxygen

Study type

Interventional

Funder types

Other

Identifiers

NCT01827683
HBOT-Fibro

Details and patient eligibility

About

The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on patients suffering from chronic pain syndrome (Fibromyalgia).

Full description

The study is a prospective, randomized, cross-over trial. Patients will be randomized into two groups (test and control) to receive the HBOT at the beginning of the trial or 2 months afterwards. The control group will receive its treatment after the elapsed two months.

This study will be a prospective, randomized cross over study. After signing a written informed consent, all patients will be invited to a 2 hour examination, including pain sensitivity examination and a series of questionnaires. In addition, prior to the beginning of the treatment all patients will have chest X-ray, neurological examination, cognitive evaluation and brain metabolism evaluation (SPECT scan). A similar evaluation will be done after the 8 weeks, test versus control time period, and another evaluation will be held after 16 weeks. The HBOT procedure will be performed in the hyperbaric chamber at Assaf Harofeh Medical Center, Israel.

The following HBOT protocol will be applied for the treated group: 8-week, 5 times a week administration of 100% O2 for 90 minutes at a pressure of 2 ATA. After 8 weeks the control group, that did not received HBOT, will receive the same HBOT protocols.

At baseline, after 2 months and after 4 months all patients will undergo complete neurologic and pain evaluation and brain SPECT scan (total of 3 evaluation and scan per patient).

Enrollment

60 patients

Sex

Female

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fibromyalgia diagnosed by physical examination of pain sensitivity, by Dolorimeter and finger pressure.

Exclusion criteria

  • any past hyperbaric oxygen therapy
  • chest x-ray pathology which does not allow the income into the hyperbaric chamber.
  • middle ear problems.
  • patients, who cannot "pump", equals middle ear pressure, effectively.
  • patients who suffer from claustrophobia.
  • inability or Refusing to sign the Informed Consent Form

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

60 participants in 2 patient groups

Hyperbaric oxygen therapy group
Active Comparator group
Description:
hyperbaric oxygen therapy during the first 2 months
Treatment:
Other: Hyperbaric oxygen
Crossed group
Other group
Description:
no active intervention during the first 2 months.After 2 months will be crossed to HBOT
Treatment:
Other: Hyperbaric oxygen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems